Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Junshi Biosciences
Pharma
AstraZeneca, BeiGene, Coherus—Fierce Pharma Asia
AZ licensed a KRAS G12D drug from Usynova. BeiGene bought a CDK2 inhibitor from Ensem. Coherus priced its Chinese PD-1 at a 20% discount to Keytruda.
Angus Liu
Dec 1, 2023 8:34am
Coherus prices China-made PD-1 at 20% discount to Keytruda
Nov 27, 2023 6:10pm
Hengrui, Takeda, and toripalimab's FDA nod—Fierce Pharma Asia
Nov 3, 2023 8:30am
Coherus spurns 'heavily discounted' pricing for new PD-1 med
Oct 30, 2023 12:10pm
AZ-Daiichi, Padcev, AbbVie—Fierce Pharma Asia
Sep 29, 2023 10:45am
Coherus hits pair of FDA hurdles
Sep 25, 2023 11:42am